What are the Challenges and Risks Associated with Nanotechnology in Cancer Treatment?
Despite its potential, the use of nanotechnology in cancer treatment also presents challenges and risks:
Biocompatibility: Ensuring that nanoparticles are biocompatible and do not elicit adverse immune responses. Toxicity: Assessing the long-term toxicity of nanoparticles, as their small size may lead to accumulation in organs and tissues. Regulatory Hurdles: Navigating the complex regulatory landscape to ensure the safety and efficacy of nanotechnology-based therapies. Manufacturing: Developing scalable and cost-effective manufacturing processes for nanoparticles.
